Catalent, Inc. Price Today
Catalent, Inc.
CTLT
Healthcare
$8.25B
๐ฐ
Market Cap
198.9
๐ธ
Price to Earnings
$0.2
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Hold Consensus
Buy |
8 |
Strong Buy |
4 |
Hold |
11 |
Sell |
1 |
Strong Sell |
0 |
CTLT Price Forecast Target
45.7 ๐ 86.0 +88%
CTLT EPS Forecast
0.2 ๐ 1.2 +409%
Financials
Profit Margin
0 %
Revenue Growth
-18.5 %
Dividend
$ 0
Held Percent
0.4% - Insiders
106.3% - Institutions
-6.7% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $901.9M
-
๐ฐ Blackrock Inc. $654.8M
-
๐ฐ Capital World Investors $613.1M
-
๐ฐ T. Rowe Price Investment Management, Inc. $550.0M
-
๐ฐ Janus Henderson Group PLC $549.6M
Stock Ideas
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across gloโฆCharlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and โฆBruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual โฆStephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at rโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Catalent, Inc. industry is Drug ManufacturersโSpecialty & Generic
The Catalent, Inc. sector is Healthcare
The Catalent, Inc. forecasted predicted Price to Earnings PE ratio is 39.1
The Catalent, Inc. Price to Earnings PE ratio is 198.9
The Market Capitalization of Catalent, Inc. is $8.25B
There are total of 179402831 float shares with 106.3% held by Institutions and 0.4% held by insiders
The MCatalent, Inc. forecasted Earnings per Share EPS is $1.2
The Catalent, Inc. Earnings per Share EPS is 0.2
The Catalent, Inc. company has $1640000000 gross profits with 0 profit margins
The Catalent, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Catalent, Inc. Revenue is $4495000064 with -0.185 revenue growth
The price target for Catalent, Inc. stock is $86.0 for the high target and $37.0 for the low target
The consensus analyst recommendations for Catalent, Inc. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Catalent, Inc. is Hold, with the following breakdown:
- Buy: 8
- Strong Buy: 4
- Hold: 11
- Sell: 1
- Strong Sell: 0
The Beta of Catalent, Inc. is 1.2
The dividend of Catalent, Inc. is $0
The dividend yield of Catalent, Inc. is 0%
The biggest institutional and mutual fund holders of Catalent, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Capital World Investors
- T. Rowe Price Investment Management, Inc.
The Catalent, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0